Dr Farah Alsarraf Fellow presenting at CSEM Annual Scientific Meeting 2022
Aliya Khan, MD, FRCPC, FACP, FACE, FASBMR
Professor of Clinical Medicine
Aliya Khan is a Clinical Professor of Medicine, Division of Endocrinology and Geriatrics, Director of the Calcium Disorders Clinic, and Director of the Fellowship in Metabolic Bone Disease at McMaster University. She graduated from the University of Ottawa Medical School with honors. She trained in Internal Medicine, Geriatric Medicine and Endocrinology and completed a fellowship in Metabolic Bone Disease at the University of Toronto. She has published over 400 scientific papers and numerous chapters and books on osteoporosis and parathyroid disease. She led the development of global guidelines for parathyroid disease, osteonecrosis of the jaw, new diagnostic criteria for hypophosphatasia, treatment guidelines for X-linked hypophosphatemia in addition to osteoporosis guidelines. She is the co-chair of the International Working Group developing best practice recommendations on bone mineral density reporting supported by 10 international imaging and skeletal health societies. She is a leading clinician researcher and is the principle investigator evaluating novel therapies for parathyroid disease including PTH , PTH analogues as well PTH1receptor agonists for hypoparathyroidism. She has received numerous international awards for outstanding contributions to Medicine including the Queen’s Diamond Jubilee Medal, International Osteoporosis Foundation award , Osteoporosis Canada Lindy Fraser award, Woman Physician of the Year Award by the American College of Physicians, Canadian Society of Endocrinology and Metabolism Dr. Jacques Genest Lecture Award. ORTOMED Medal from the Italian Society of Orthopedics and Medicine, King Charles Coronation medal and 2025 American Association of Clinical Endocrinologists Outstanding International Clinician award. She was awarded the FIRMO Parathyroid Medal at the Endocrine Society pre-meeting in 2025 in recognition of her outstanding contributions to advancing research in parathyroid disease. She is recognized as being in the top 0.1% of the world experts in hyperparathyroidism by Expertscape.
Dr. Sarah Khan
MD
Dr Sarah Khan MD FRPC is a staff clinician at the Bone Research and Education Clinic (BREC) and at Credit Valley Hospital (Trillium Health Partners). She graduated from the University of Toronto School of Medicine in 2015. She went on to complete her Internal Medicine Residency and Endocrinology Fellowship at the University of Toronto (UofT) as well. She has a keen interest in treating patients with metabolic bone diseases at BREC. Outside of clinical work she is actively partaking as a co-investigator in clinical trials to investigate new treatment options for patients with hypoparathyroidism. She is also pursing her Master of Education at the Ontario Institute of Studies in Education (OISE) at UofT.
Dr. Lora Giangregorio
Kinesiologist
Lora Giangregorio, PhD is a Professor and Tier 1 Canada Research Chair in Bone Health and Exercise Science in the Department of Kinesiology and Health Sciences at the University of Waterloo. She leads the Bone Health and Exercise Science Lab, or BonES lab. The BonES lab team leads research on physical activity for fall and fracture prevention. Dr. Giangregorio is a member of the Scientific Advisory Council for Osteoporosis Canada and was on the leadership team that developed the 2020 Canadian 24-hour Movement Guidelines. She also led the Exercise Working Group for the 2023 Clinical Practice Guidelines for Management of Osteoporosis and Fracture Prevention in Canada.
Endocrine Society 2023: Dr. Aliya Khan and Dr. Sarah Khan
